Segment & Geographic Data Quant-Grade Normalized Data API & CSV Delivery

Guided Therapeutics Inc's Business Segments

Guided Therapeutics Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Reportable Segments
2
Per the company's own filing, this quarter
Largest Segment
Turkish
60.9% of revenue
Total Revenue
$ 0
Consolidated, this quarter
Regions Reported
-
Geographic regions, this quarter

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/GTHP/segments
https://api.csimarket.com/api/v1/companies/GTHP/geographic
https://api.csimarket.com/api/v1/companies/GTHP/exposure
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment -

61%largest
  • Turkish60.9%
  • Turkish Ministry of Health39.1%

Revenue by Reportable Segment -

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
Turkish$ 060.9%-
Turkish Ministry of Health$ 039.1%-

Annual Results

Revenue Share by Reportable Segment -

61%largest
  • Turkish60.9%
  • Turkish Ministry of Health39.1%

Revenue by Reportable Segment -

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
Turkish$ 060.9%-
Turkish Ministry of Health$ 039.1%-

Description of Guided Therapeutics Inc

Guided Therapeutics Inc. (GT) is a medical technology company headquartered in Norcross, Georgia, United States. It specializes in the development and commercialization of non-invasive diagnostic devices that aid in the early detection and monitoring of diseases, primarily cervical cancer.

GT's flagship product is the LuViva® Advanced Cervical Scan, which utilizes a patented technology called light-based spectroscopy. This device is designed to provide an objective and accurate assessment of cervical tissue health, detecting pre-cancerous and cancerous conditions at an early stage. The LuViva system consists of a handheld device and a console that provides real-time analysis and displays the results to healthcare professionals.

The LuViva device works by analyzing the fluorescence and reflectance properties of cervical tissue. By illuminating the cervix with different wavelengths of light, the device can measure and analyze the biochemical and structural changes in the tissue, providing valuable information about its health status. This non-invasive approach eliminates the need for invasive procedures like biopsies, which can be uncomfortable for patients and may lead to complications.

The LuViva device has been clinically tested and approved by various regulatory agencies, including the US Food and Drug Administration (FDA) and the European Union. It has been proven to accurately identify cervical abnormalities, including precancerous and cancerous lesions, with high sensitivity and specificity.

In addition to cervical cancer, GT is actively expanding its technology platform to address other areas of unmet medical needs. The company is conducting research and development efforts to develop advanced diagnostic devices for detecting breast, gastrointestinal, and lung cancers using its light-based spectroscopy technology.

Guided Therapeutics Inc. is committed to improving global healthcare outcomes by offering cost-effective, accurate, and non-invasive diagnostic solutions. By facilitating early detection and monitoring of diseases, the company aims to enable timely interventions and improve patient outcomes. GT collaborates with healthcare providers and organizations worldwide to make its innovative technology accessible to a larger population.

Overall, Guided Therapeutics Inc. stands as a leader in the field of non-invasive diagnostic devices and is dedicated to revolutionizing the early detection and monitoring of diseases, particularly cervical cancer.
Guided Therapeutics Inc. specializes in the field of medical diagnostics, particularly focusing on innovative technologies for the early detection of cancer, especially for conditions affecting the gastrointestinal tract. The company has developed a range of products and services aimed at improving patient outcomes through advanced diagnostic methodologies.

Segments:

1. Product Development: Guided Therapeutics is engaged in the ongoing research and development of diagnostic devices and procedures aimed at enhancing the efficacy of cancer detection. This segment encompasses the innovation of new technologies as well as the improvement of existing systems.

2. Clinical Services: This segment includes the application of guided therapeutic techniques in clinical environments, providing services that leverage their patented technologies for diagnostic purposes. This may involve partnerships with healthcare providers and facilities to enable better patient care.

3. Regulatory and Compliance: Guided Therapeutics ensures that their products meet the stringent guidelines set forth by regulatory bodies, working diligently to secure approvals and maintain compliance throughout all phases of product development and service provision.

Products:

1. LuViva Advanced Cervical Imaging System: This is one of the flagship products of Guided Therapeutics. The LuViva system is designed for non-invasive imaging of cervical tissue, allowing healthcare providers to detect potential abnormalities that may indicate the presence of precancerous or cancerous conditions. The technology uses fluorescence spectroscopy to provide a real-time assessment of cervical health.

2. Diagnostic Devices: In addition to the LuViva system, Guided Therapeutics is involved in the development of various diagnostic devices aimed at detecting pre-cancerous lesions in other anatomical areas, leveraging similar technologies to identify abnormalities early.

Services:

1. Medical Training and Support: Guided Therapeutics offers training programs for healthcare professionals to effectively utilize their diagnostic technologies. This includes comprehensive education on how to operate their imaging systems, interpret results, and integrate these technologies into patient care.

2. Clinical Consultation: The company may provide consultation services to healthcare providers seeking to implement advanced diagnostics in their practice. This involves guidance on workflow optimization, device implementation, and patient management strategies to enhance the diagnostic process.

3. Research Collaborations: Guided Therapeutics often engages in partnerships with research institutions and medical facilities to further study and validate their technologies. Through these collaborations, they seek to expand the understanding of their devices efficacy and improve diagnostic methodologies.

4. Patient Education Resources: To facilitate broader awareness and understanding of cervical health and the importance of early detection, Guided Therapeutics may develop resources aimed at educating patients. These could include brochures, informational websites, or community outreach programs.

Innovation Focus:

Guided Therapeutics is continually looking to evolve their offerings through innovation. Their focus on research aims to discover more accurate and efficient ways to detect cancer at earlier stages, thereby improving treatment outcomes and patient quality of life. By investing in new technologies and refining existing products, the company endeavors to remain at the forefront of cancer diagnostics.

In summary, Guided Therapeutics Inc. operates mainly in the medical diagnostics sector, with a primary focus on cancer detection through advanced imaging technologies. Their product line includes innovative systems like the LuViva Advanced Cervical Imaging System, and they offer a variety of services to support healthcare professionals in utilizing their diagnostic tools effectively. Their commitment to research, education, and patient care underscores their mission to enhance early cancer detection and ultimately improve patient outcomes.
Get the full CSIMarket dataset: Subscribe API Connect Your AI